NCT00874458

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Centre Antoine Lacassagne · Academic / Other
• Sex: Female
• Age: 18 Years – 120 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and find out how far the disease has spread. PURPOSE: This clinical trial is studying how well MRI works in assessing tumor size in women with ductal carcinoma in situ.

Detailed description

OBJECTIVES: Primary * Assess the contribution of MRI in accurately determining tumor size in women with ductal breast carcinoma in situ (DCIS). Secondary * Evaluate the sensitivity of MRI in detecting DCIS. * Evaluate the contribution of mammography in accurately determining tumor size. * Compare the contribution of MRI vs mammography in assessing tumor extension. * Compare the contribution of MRI vs mammography in assessing dense breasts. * Evaluate the morphology of DCIS by MRI. * Evaluate the curve of dynamic MRI in assessing DCIS. * Evaluate the impact of nuclear grade of DCIS by MRI. * Evaluate the rate of revision surgery. OUTLINE: Patients undergo clinical examination, mammography, ultrasound imaging, unilateral breast MRI, and tissue sampling.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
PROCEDURE	magnetic resonance imaging
PROCEDURE	radiomammography
PROCEDURE	ultrasound imaging

Timeline

• Start date: 2007-04-01
• Primary completion: 2011-05-01
• Completion: 2013-12-01
• First posted: 2009-04-02
• Last updated: 2025-09-30

Locations

1 site across 1 country: France